Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 3/2020

01.09.2020 | editorial

News from ASH 2019

verfasst von: Eberhard Gunsilius

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten
share
TEILEN

Excerpt

The 61st ASH (American Society of Hematology) annual meeting and exposition was held in Orlando (FL, USA), December 7–10, 2019, with more than 25,000 attendees from more than 115 countries and almost 4900 featured abstracts. The constantly growing information overload at such “mega-meetings” does not always make it easy to keep an overview and separate the wheat from the chaff. I am happy and grateful that specialists with proven preclinical and clinical expertise in their field have agreed to do this job for us. In this issue of MEMO, selected highlights from the ASH meeting 2019 regarding chronic lymphocytic leukemia, aggressive B‑cell lymphomas, multiple myeloma, and chronic myeloid leukemia are summarized by these experts. The latest developments in chimeric antigen receptor (CAR)T-cell therapy, also a main topic at ASH 2019, have been covered in the March issue of this journal [ 1]. …
Metadaten
Titel
News from ASH 2019
verfasst von
Eberhard Gunsilius
Publikationsdatum
01.09.2020
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2020
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-020-00629-6